Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001255294-12-000830
Filing Date
2012-11-19
Accepted
2012-11-19 12:06:34
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q/A 222324
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7995
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7994
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 3649
5 GRAPHIC1 image_001.jpg GRAPHIC 5855
  Complete submission text file 0001255294-12-000830.txt   1191234

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE skvi-20120331.xml EX-101.INS 127857
7 XBRL SCHEMA FILE skvi-20120331.xsd EX-101.SCH 10034
8 XBRL DEFINITION FILE skvi-20120331_def.xml EX-101.DEF 6208
9 XBRL LABEL FILE skvi-20120331_lab.xml EX-101.LAB 68650
10 XBRL PRESENTATION FILE skvi-20120331_pre.xml EX-101.PRE 53640
Mailing Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD SUITE 10 LAS VEGAS NV 89120 7024337154
SKINVISIBLE INC (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-25911 | Film No.: 121213719
SIC: 2834 Pharmaceutical Preparations